Attenuation of Carbon Tetrachloride-Induced Hepatic Injury with Curcumin-Loaded Solid Lipid Nanoparticles

A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs

(2013) Bhandari Rohit et al.   Current Nanoscience

Effects of nanoparticle-encapsulated curcumin on arsenic-induced liver toxicity in rats

(2013) Palanisamy Sankar et al.   ENVIRONMENTAL TOXICOLOGY

Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain

(2013) Vandita Kakkar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment

(2013) M. M. Yallapu et al.   MOLECULAR CANCER THERAPEUTICS

Curcumin Nanoparticles Attenuate Neurochemical and Neurobehavioral Deficits in Experimental Model of Huntington’s Disease

(2013) Rajat Sandhir et al.   NEUROMOLECULAR MEDICINE

Efficacy of Biodegradable Curcumin Nanoparticles in Delaying Cataract in Diabetic Rat Model

(2013) Charitra N. Grama et al.   PLoS One

Curcumin encapsulated in chitosan nanoparticles: A novel strategy for the treatment of arsenic toxicity

(2012) Abhishek Yadav et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles

(2012) Rohit Bhandari et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease

(2012) Anila Mathew et al.   PLoS One

Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

(2011) Janos Feher et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

ADME Properties of Herbal Medicines in Humans: Evidence, Challenges and Strategies

(2011) Shu-Ming He et al.   CURRENT PHARMACEUTICAL DESIGN

Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain

(2011) Vandita Kakkar et al.   FOOD AND CHEMICAL TOXICOLOGY

A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation

(2011) Savita Bisht et al.   LABORATORY INVESTIGATION

Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles

(2010) LianDong Hu et al.   AAPS PHARMSCITECH

Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin

(2010) Vandita Kakkar et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases

(2010) Lanjuan Li et al.   Nano Today

Determining the Effects of Lipophilic Drugs on Membrane Structure by Solid-State NMR Spectroscopy: The Case of the Antioxidant Curcumin

(2009) Jeffrey Barry et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Pharmacological actions of curcumin in liver diseases or damage

(2009) Yadira Rivera-Espinoza et al.   LIVER INTERNATIONAL

Emodin protects rat liver from CCl4-induced fibrogenesis via inhibition of hepatic stellate cells activation

(2009) Miao-Xian Dong et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Potential of solid lipid nanoparticles in brain targeting

(2008) Indu Pal Kaur et al.   JOURNAL OF CONTROLLED RELEASE

Hepatoprotective activity of Clerodendrum inerme against CCL4 induced hepatic injury in rats

(2007) N. Gopal et al.   FITOTERAPIA

Beneficial drugs for liver diseases

(2007) Pablo Muriel et al.   JOURNAL OF APPLIED TOXICOLOGY

Foods and liver health

(2007) Filomena Morisco et al.   MOLECULAR ASPECTS OF MEDICINE